6 January 2025
Graham Shelton, our Founder and Chairman, stepped down at the end of December 2024. We were proud to mark his retirement at our Oxford party, and present him with a book of memories from current and former colleagues and clients from around the world.
Oxford PharmaGenesis is global, award-winning and independent. Our unique HealthScience approach combines audience insights, best practice in omnichannel communications and proven behaviour change techniques to maximize your impact. From Medical Affairs to Market Access, join us to explore new frontiers.
Integrated evidence generation planning is more effective than traditional evidence generation planning. It can help pharmaceutical organizations to improve patient care and outcomes.
The 2024 European meeting of the International Society for Medical Publication Professionals (ISMPP), held on 23–24 January 2024, saw professionals from all areas of medical communications gather in the Novotel London West to shelter from some quintessentially British weather. I started working at Oxford PharmaGenesis only a couple of months before the world locked down…
Following an invitation from MAPS (Medical Affairs Professional Society), Oxford PharmaGenesis Communications Director Gary Male has joined the Evidence Generation Focus Area Working Group (FAWG). He will volunteer his time and expertise to help to educate the society’s membership of Medical Affairs professionals about this specialty area.
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published today in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis is global, award winning and independent. Our unique HealthScience approach uses proven behaviour change techniques to maximize the impact of your communications and to ensure they resonate with the target audience. Talk to us to learn how we can help you improve collaboration, innovation, and strategy and planning.
